This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US
December 15 - 18, 2024
Marriott Marquis San DiegoLive In-Person Event: December 15 - 18, 2024

Josef Gramespacher, PhD
Co-founder and Senior Scientist at EpiBiologics


Josef Gramespacher is a co-founder and current senior scientist at EpiBiologics, a company focused on developing first-in-class antibody-based therapies to degrade disease driving membrane and extracellular proteins. Prior to joining EpiBiologics, Josef was a postdoctoral fellow at UCSF working under the supervision of Jim Wells.

Agenda Sessions

  • Harnessing Modular E3 Ligase and Cytokine Receptor Targeting Chimeras to Degrade Cell-surface and Extracellular Proteins


At this event